Neurosync Pharmaceuticals Private Limited
About Neurosync Pharmaceuticals Private Limited
Data last updated:
Neurosync Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It was incorporated on 29 November 2023.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U46497UP2023PTC193176.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Arti Tiwari and Brijesh Kumar Verma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Lucknow, Uttar Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.88 Lakh. For the same year it recorded a net profit of ₹15,123 (net margin 8.1%) and EBITDA of ₹20,761 (EBITDA margin 11.1%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/O Arti Tiwari, Shanti Nagar Dhodhankheda, Lucknow, Uttar Pradesh, India – 226002
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Neurosync Pharmaceuticals Private Limited
The main business activity of Neurosync Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Neurosync Pharmaceuticals Private Limited FY 2025 filings available
Neurosync Pharmaceuticals Private Limited reported revenue of ₹1.88 Lakh for FY 2025.
Financial Statement Summary of Neurosync Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | ₹20,761 | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | ₹15,123 | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Neurosync Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 11.1% | •••• |
| Net Profit Margin | 8.1% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Neurosync Pharmaceuticals are in the company report.
Financial statements from FY 2024
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Neurosync Pharmaceuticals Private Limited
Neurosync Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Revenue, net profit, margin and growth of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Neophyte Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | - | Patna, Bihar, India |
| Vindhyachal Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | - | Umarkhed, Maharashtra, India |
| Megsan Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | - | Cuttack, Orissa, India |
| Experon Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | - | Gorakhpur, Uttar Pradesh, India |
| Hindraj Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | - | Delhi, India |
| Neurosync Pharmaceuticals Private Limited this company | •••• | •••• | •••• | •••• | - | Lucknow, Uttar Pradesh, India |
| Sofitt Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | - | Pataudi, Haryana, India |
| Reveto Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | - | Rajura, Maharashtra, India |
| Dover Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | - | Bengaluru, Karnataka, India |
| Auszug Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | - | Hyderabad, Telangana, India |
| Nuvitol Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | - | Bangalore, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Neurosync Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.
Board of Directors of Neurosync Pharmaceuticals Private Limited
Neurosync Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arti Tiwari | Director | 29 Nov 2023 | 2 Years 10 Months | Current |
| Brijesh Kumar Verma | Director | 29 Nov 2023 | 2 Years 10 Months | Current |
| Pratibha Tripathi | Director | 29 Nov 2023 | 2 Years 10 Months | Current |
Charges & Borrowings of Neurosync Pharmaceuticals Private Limited
Neurosync Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Neurosync Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Neurosync Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Neurosync Pharmaceuticals Private Limited
Neurosync Pharmaceuticals Private Limited has 3 board changes on record since 2023: 3 appointments. The latest: Arti Tiwari was appointed as Director on 29 Nov 2023.
Credit Ratings, Litigation & Regulatory Alerts for Neurosync Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Neurosync Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Neurosync Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Neurosync Pharmaceuticals Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Neurosync Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neurosync Pharmaceuticals Private Limited
Neurosync Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. It was incorporated on 29 November 2023 (3+ years old) and is registered under CIN U46497UP2023PTC193176.
Neurosync Pharmaceuticals reported revenue of ₹1.88 Lakh for FY 2025.
Neurosync Pharmaceuticals has 3 current directors:
- Arti Tiwari - Director
- Brijesh Kumar Verma - Director
- Pratibha Tripathi - Director
Neurosync Pharmaceuticals reported a net profit of ₹15,123 (net margin 8.1%) and EBITDA of ₹20,761 (EBITDA margin 11.1%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Neurosync Pharmaceuticals is U46497UP2023PTC193176. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Neurosync Pharmaceuticals was incorporated on 29 November 2023, making it 3+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Neurosync Pharmaceuticals by revenue are Neophyte Pharmaceuticals Private Limited, Vindhyachal Pharmaceuticals Private Limited, Megsan Pharmaceuticals Private Limited, Experon Pharmaceuticals Private Limited, Hindraj Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Arti Tiwari was appointed as Director on 29 Nov 2023. Brijesh Kumar Verma was appointed as Director on 29 Nov 2023. Pratibha Tripathi was appointed as Director on 29 Nov 2023.
The registered office of Neurosync Pharmaceuticals is at CO Arti Tiwari, Shanti Nagar Dhodhankheda, Lucknow, Uttar Pradesh, India – 226002.
Neurosync Pharmaceuticals has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh.
No. Neurosync Pharmaceuticals is not listed on any stock exchange. It is an unlisted company.